On October 23, 2025, ATAI Life Sciences N.V. amended its Share Purchase Agreement with Beckley Psytech, reducing the number of shares to be issued by 1,221,712, bringing the new total to 103,823,190 shares. Additionally, 900,901 shares will be issued to Cantor Fitzgerald & Co., with the amendments outlined affecting costs and shareholder voting requirements.